KRONOX
Kronox Lab Sciences Limited
High Purity Specialty Fine Chemicals manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
kronoxlabsciences.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Kronox Lab Sciences is a company based in Vadodara, Gujarat, whose promoters sold a 64.26% controlling stake to Indo Borax & Chemicals in September 2026, triggering an open offer to public shareholders.
Company snapshot
48thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Net margin of 27.3% — the business keeps a healthy share of every rupee it earns.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 Cr | 25 Cr | 25 Cr | 24 Cr | 26 Cr | 24 Cr | 26 Cr | 25 Cr | 26 Cr | 28 Cr |
| Operating expenses (approx.) | 14 Cr | 17 Cr | 16 Cr | 16 Cr | 18 Cr | 16 Cr | 17 Cr | 17 Cr | 17 Cr | 19 Cr |
| EBITDA | 8 Cr | 8 Cr | 9 Cr | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 8 Cr | 10 Cr | 9 Cr |
| OPM % | 35.4% | 32.6% | 35.4% | 34.8% | 29.7% | 32.8% | 33.9% | 31.7% | 36.4% | 31.7% |
| Other income | 0.83 Cr | 0.43 Cr | 0.36 Cr | 0.82 Cr | 0.91 Cr | 0.87 Cr | 1 Cr | 1 Cr | 2 Cr | 1 Cr |
| Interest | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0.04 Cr | 0.04 Cr | 0.04 Cr | 0.03 Cr |
| Depreciation | 0.29 Cr | 0.33 Cr | 0.34 Cr | 0.36 Cr | 0.35 Cr | 0.40 Cr | 0.47 Cr | 0.52 Cr | 0.66 Cr | 0.45 Cr |
| Profit before tax | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 11 Cr | 10 Cr |
| Tax % | 29.9% | 26.0% | 26.6% | 26.0% | 24.0% | 25.6% | 27.3% | 23.4% | 27.1% | 25.6% |
| Net profit | 6 Cr | 6 Cr | 6 Cr | 7 Cr | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 8 Cr | 7 Cr |
| EPS (₹) | ₹1.60 | ₹1.67 | ₹1.76 | ₹1.77 | ₹1.72 | ₹1.70 | ₹1.82 | ₹1.79 | ₹2.18 | ₹2.00 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 62 Cr | 82 Cr | 96 Cr | 90 Cr | 100 Cr | 101 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 48 Cr | 63 Cr | 74 Cr | 62 Cr | 67 Cr | 67 Cr | Sign in free for the trailing twelve months |
| EBITDA | 15 Cr | 20 Cr | 22 Cr | 28 Cr | 33 Cr | 34 Cr | Sign in free for the trailing twelve months |
| OPM % | 23.7% | 23.9% | 23.0% | 31.5% | 33.1% | 33.9% | Sign in free for the trailing twelve months |
| Other income | 0.78 Cr | 1 Cr | 2 Cr | 2 Cr | 3 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Interest | 0.38 Cr | 0.41 Cr | 0.09 Cr | 0 Cr | 0 Cr | 0.11 Cr | Sign in free for the trailing twelve months |
| Depreciation | 2 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 13 Cr | 18 Cr | 22 Cr | 29 Cr | 34 Cr | 37 Cr | Sign in free for the trailing twelve months |
| Tax % | 26.4% | 25.8% | 25.6% | 25.4% | 26.2% | 25.9% | Sign in free for the trailing twelve months |
| Net profit | 10 Cr | 14 Cr | 17 Cr | 21 Cr | 25 Cr | 28 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹2.40 | ₹3.49 | ₹4.30 | ₹5.81 | ₹6.91 | ₹7.51 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 0.0% | 7.3% | 6.7% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 0.24 Cr | 0.24 Cr | 37 Cr | 37 Cr | 37 Cr | 37 Cr |
| Reserves | 27 Cr | 40 Cr | 8 Cr | 29 Cr | 53 Cr | 79 Cr |
| Borrowings | 0.01 Cr | 0.64 Cr | — | — | — | 2 Cr |
| Other liabilities | 11 Cr | 16 Cr | 9 Cr | 8 Cr | 9 Cr | 10 Cr |
| Total liabilities | 38 Cr | 57 Cr | 54 Cr | 74 Cr | 99 Cr | 128 Cr |
| Fixed assets (net) | 6 Cr | 9 Cr | 16 Cr | 26 Cr | 28 Cr | 29 Cr |
| CWIP | 0.40 Cr | — | — | 0.49 Cr | 0.76 Cr | 0.88 Cr |
| Investments | 0.03 Cr | 0.03 Cr | 0.03 Cr | 0 Cr | 0.03 Cr | 0.03 Cr |
| Inventories | 5 Cr | 8 Cr | 9 Cr | 9 Cr | 6 Cr | 8 Cr |
| Trade receivables | 15 Cr | 26 Cr | 19 Cr | 18 Cr | 20 Cr | 21 Cr |
| Cash & bank | 1 Cr | 0.29 Cr | 2 Cr | 3 Cr | 3 Cr | 3 Cr |
| Other assets | 9 Cr | 14 Cr | 8 Cr | 18 Cr | 41 Cr | 66 Cr |
| Total assets | 38 Cr | 57 Cr | 54 Cr | 74 Cr | 99 Cr | 128 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 11 Cr | 9 Cr | 20 Cr | 17 Cr | 32 Cr | 24 Cr |
| Cash from investing | -3 Cr | -8 Cr | -6 Cr | -17 Cr | -30 Cr | -24 Cr |
| Cash from financing | -7 Cr | -0.67 Cr | -13 Cr | 0 Cr | -2 Cr | -0.36 Cr |
| Net cash flow | 1 Cr | 0.76 Cr | 0.75 Cr | 0.10 Cr | 0.45 Cr | -0.29 Cr |
| Free cash flow (OCF − Capex) | 10 Cr | 5 Cr | 11 Cr | 5 Cr | 29 Cr | 21 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 50.7% | 45.8% | 50.2% | 43.1% | 38.0% | 31.8% |
| ROE % | 36.3% | 33.8% | 37.2% | 32.2% | 28.1% | 23.8% |
| Debtor days | 90 | 114 | 71 | 72 | 72 | 76 |
| Inventory days | 58 | 57 | 58 | 75 | 48 | 65 |
| Days payable | 69 | 87 | 49 | 51 | 0 | 51 |
| Cash conversion cycle | 79 | 84 | 79 | 96 | 120 | 90 |
| OCF / EBITDA % | 76.4% | 45.8% | 89.4% | 61.5% | 98.0% | 69.7% |
| OCF / EBITDA % (3 years) | — | — | 70.8% | 65.8% | 83.4% | 77.1% |
| Debt / equity | 0.0005 | 0.02 | — | — | — | 0.01 |
| Current ratio | 3.30 | 3.21 | 3.85 | 6.07 | 102.04 | 7.60 |
| Net debt / EBITDA | -0.07 | 0.02 | -0.11 | -0.09 | -0.09 | -0.03 |